Abstract
The first cord blood transplantation (CBT) was performed in a 5-year-old boy with acute mylogenous leukemia from his HLA-identical sibling donor in 1994. Since then there have been 17 related and 131 unrelated CBTs in Japan. Overall survival and disease-free survival (DFS) were over 70% in sibling donor CBT. DFS of unrelated CBT in leukemia and other hematological malignancies was 43%, and OS of UCBT in non-malignant diseases was 63%. HLA disparity between the donor and the recipient did not affect the incidence and severity of acute graft-versus-host disease (GVHD) or survival. Cell dose was the most important factor for engraftment and survival both in malignant and in non-malignant diseases. The Japanese government has recently established the nationwide cord blood bank network, and eight local cord blood banks are financially supported by the government. 20 000 units of CB are planned to be collected and stored in the next 5 years by this network. Bone Marrow Transplantation (2000) 25 , Suppl. 2, S68–S70.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Kato, S., Nishihira, H., Hara, H. et al. Cord blood transplantation and cord blood bank in Japan. Bone Marrow Transplant 25 (Suppl 2), S68–S70 (2000). https://doi.org/10.1038/sj.bmt.1702358
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702358
Keywords
This article is cited by
-
Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells
International Journal of Hematology (2001)